Identification of Histopathologic Criteria to Differentiate Autoimmune Hepatitis (AIH) from Chronic Viral Hepatitis (B, C) in Liver Biopsy Samples

Document Type : Original Article (s)

Authors

1 Associate Professor, Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Assistant Professor, Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Resident Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Chronic hepatitis is a common disease in the community. Differential diagnosis of hepatitis is very important in the treatment of this disease; as applying the wrong treatment method can lead to reinforcement and aggravate. This study aimed to determine the prevalence of histopathologic criteria for distinguishing between and for accurate differentiation of chronic viral hepatitis from autoimmune hepatitis.Methods: In a cross-sectional study, 45 patients with autoimmune hepatitis, 34 patients with hepatitis B and 33 patients with hepatitis C were investigated for presence of histopathological criteria. The data were analyzed using chi-square and diagnostic tests.Findings: Among the 12 indicators, 5 criteria including interface hepatitis, lymphoid follicle in port area, emperipolesis, hepatic rosette and ground glass hepatocyte had the ability to differentiate types of hepatitis. The predictive percent of above parameters for autoimmune hepatitis was 80%, for hepatitis B was 76.5% and for hepatitis C was 69.7%.Conclusion: Based on the results, histopathological parameters can differentiate between types of chronic hepatitis in patients at an acceptable level which among them, interface hepatitis is used to differentiate autoimmune hepatitis and chronic hepatitis C from chronic hepatitis B; lymphoid follicle in port area is used to differentiate chronic hepatitis C, emperipolesis and hepatic rosette to differentiate autoimmune hepatitis and ground glass hepatocyte to differentiate chronic hepatitis B from the other two types.

Keywords

References

  1. Guido M, Mangia A, Faa G. Chronic viral hepatitis: the histology report. Dig Liver Dis 2011; 43(Suppl 4): S331-S343.
  2. Firpi RJ, Nelson DR. Viral hepatitis: manifestations and management strategy. Hematology Am Soc Hematol Educ Program 2006; 375-80.
  3. Malik TA, Saeed S. Autoimmune hepatitis: a review. J Pak Med Assoc 2010; 60(5): 381-7.
  4. Desmet VJ. Liver lesions in hepatitis B viral infection. Yale J Biol Med 1988; 61(1): 61-83.
  5. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45(2): 507-39.
  6. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992; 15(4): 572-7.
  7. Vyberg M. The hepatitis-associated bile duct lesion. Liver 1993; 13(6): 289-301.
  8. Tanikawa K, Kage M, Komuta M, Nakashima O, Yano H, Yatsuhashi H, et al. Pathological analysis of oxyphilic granular hepatocytes and hepatocellular mitochondria in chronic hepatitis C. Hepatol Res 2007; 37(6): 425-32.
  9. Clement S, Negro F. Hepatitis C virus: the viral way to fatty liver. J Hepatol 2007; 46(6): 985-7.
  10. Haque S, Chandra B, Gerber MA, Lok AS. Iron overload in patients with chronic hepatitis C: a clinicopathologic study. Hum Pathol 1996; 27(12): 1277-81.
  11. Goldin RD, Levine TS, Foster GR, Thomas HC. Granulomas and hepatitis C. Histopathology 1996; 28(3): 265-7.
  12. Gabriel A, Kukla M, Wilk M, Liszka L, Petelenz M, Musialik J. Angiogenesis in chronic hepatitis C is associated with inflammatory activity grade and fibrosis stage. Pathol Res Pract 2009; 205(11): 758-64.
  13. Manns MP, Vogel A. Autoimmune hepatitis, from mechanisms to therapy. Hepatology 2006; 43(2 Suppl 1): S132-S144.
  14. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002; 36(2): 479-97.
  15. Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48(1): 169-76.
  16. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006; 354(1): 54-66.
  17. Dalekos GN, Zachou K, Liaskos C, Gatselis N. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview. Eur J Intern Med 2002; 13(5): 293-303.
  18. Dalekos GN, Wedemeyer H, Obermayer-Straub P, Kayser A, Barut A, Frank H, et al. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment. J Hepatol 1999; 30(3): 366-75.
  19. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31(5): 929-38.
  20. Kumari N, Kathuria R, Srivastav A, Krishnani N, Poddar U, Yachha SK. Significance of histopathological features in differentiating autoimmune liver disease from nonautoimmune chronic liver disease in children. Eur J Gastroenterol Hepatol 2013; 25(3): 333-7.
Journal of Isfahan Medical School
Volume 34, Issue 406 - Serial Number 406
September and October 2017
Pages 1344-1350

Files

History

  • Receive Date: 19 September 2016
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics